Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 11:22:12 AM CDT

Learn about Newser Points »

« Back to the grid | Next story »

Feds OK Wyeth's New Antidepressant

Posted Feb 29, 08 7:41 PM CST in Science & Health,  Business 

(Newser) – Antidepressant Effexor XR will soon lose patent protection, and maker Wyeth is hoping Pristiq, the successor drug approved today by the FDA, will soften the financial blow. Higher-ups at the company gush over Pristiq's advantages, including zero acclimation time and no liver interaction, and hope that sales will offset losses to generic versions of Effexor, the New York Times reports.

Wyeth lauds the drug for the same reason that skeptics doubt claims of increased effectiveness: Pristiq is a “metabolite,” basically Effexor after human consumption. Wyeth hopes for sales similar to Effexor’s nearly $4 billion a year, and the market responded well to the FDA approval—but industry insiders doubt it will live up to expectations “with no clear advantages over” other antidepressants.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Antidepressant Studies Distort Drugs' Usefulness

    Jan 16, 08 9:37 PM CST
    Antidepressant Studies Distort Drugs' Usefulness Roughly half of the medical studies involving antidepressants that found little or no effect on patients have gone unpublished or had their findings mischaracterized as positive, a new study reveals. The emphasis on publishing only studies with glowing reviews gives patients and doctors a false sense of the effectiveness of drugs such as Zoloft and Effexor, the Wall Street Journal reports. More »

It's unknown when Pristiq could hit pharmacy shelves. (AP Photo/Danny Johnston)   (Associated Press)
The lobby of the headquarters of pharmaceutical company Wyeth is shown in Madison, N.J., in this Oct. 19, 2006 file photo. The FDA's demand for further testing of Pristiq, a nonhormonal drug for menopause...   (Associated Press)
Wyeth headquarters in Madison, N.J., is seen in this April 28, 2004 file photo. (AP Photo/Daniel Hulshizer,File)   (Associated Press)
Effexor XR 75mg 1 week sample pack front   ((c) gloom)
Effexor XR 37.5mg / 75mg 2 weeks sample pack inside   ((c) gloom)
Effexor XR 37.5mg / 75mg 2 weeks sample pack front   ((c) gloom)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (1 of 2)

Tags

stock market  • FDA  • antidepressant  • Wyeth  • metabolism  • Effexor  • patent expiration


Loading...

Loading...

Today's Most Popular


Other Business Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »